BIOGEN INC. (NASDAQ:BIIB) filed a Form 8-K with the Securities and Exchange Commission on February 11, 2026, disclosing a material event.
BIOGEN INC.'s stock currently trades at $191.20 with a market capitalization of $25.3B. The Healthcare company's stock moved following the disclosure.
